Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 19th August 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Updated advice on lactating cow intramammary antibiotics
The VMD was informed of supply problems with certain lactating cow antibiotics earlier this year.

Multiject IMM Intramammary Suspension will arrive January 2021.

The Veterinary Medicines Directorate (VMD) has updated its advice on the availability of lactating cow intramammary antibiotics.

Earlier this year, the VMD were informed by Marketing Authorisation Holders (MAHs) of supply problems with certain lactating cow intramammary antibiotics.

On Tuesday (18 August) the list of anticipated resolution dates was updated. Combiclav Intramammary Suspension for Lactating Cows is now expected November 2020 while Multiject IMM Intramammary Suspension will arrive January 2021.

The full list is as follows:

Product Anticipated Resolution Date
Synulox Lactating Cow Intramammary Suspension (42058/4143) October-December 2020
Tetra-Delta Intramammary Suspension (42058/4152) October-December 2020
Ubro Yellow Milking Cow Intramammary Suspension (08327/4305) Product discontinued – no return date
Multiject IMM Intramammary Suspension (02000/4062) January 2021
Albiotic 330mg/100mg Intramammary Solution (30282/4035)  End of July 2020
Mastiplan LC, 300mg/20mg Intramammary Suspension (01708/4534)  End of June 2020
Cobactan MC Intramammary Suspension for Lactating Cows (42810/4000 End of June 2020
Combiclav Intramammary Suspension for Lactating Cows (02000/4424)  November 2020

The following lactating cow intramammary products have been reported as available for veterinary surgeons to purchase:

Ubropen 600 mg Intramammary Suspension for Lactating Cows (42810/4000)
Ubrolexin Intramammary Suspension for Lactating Dairy Cows (08327/4306)
Procapen Injector 3g intramammary suspension for cattle (24745/4023)
Orbenin L.A. 200mg Intramammary Suspension (42058/4090)
Pathocef 250mg Intramammary Suspension (42058/4094)*
Cefimam LC, 75 mg Intramammary
Pathocef 250mg Intramammary Suspension (42058/4094)*
Cefimam LC, 75 mg Intramammary Ointment for Lactating Cows (02000/4387)

Further details on the supply situation for individual UK-authorised product can be obtained through the MAH or a wholesale dealer.

 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.